Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 140 No. 4546 (2010)

Chlamydia trachomatis infection in a Swiss prison: a cross sectional study

  • AS Steiner
  • BS Elger
DOI
https://doi.org/10.4414/smw.2010.13126
Cite this as:
Swiss Med Wkly. 2010;140:w13126
Published
08.11.2010

Summary

BACKGROUND: Chlamydia trachomatis infection (CTI) is the most frequent sexually transmitted infection in Switzerland and its prevalence in correctional settings is currently unknown. The aim of this study was to determine the prevalence of CTI and associated risk factors in a population of inmates aged 18–35 years.

METHODS: Inmates attending the health care unit of the largest Swiss remand prison from June 2008 to May 2009 were invited to participate in this cross-sectional study. All participants completed a questionnaire and provided a first-void urine specimen for CTI testing based on a PCR assay. Univariate and multivariate logistic regression analyses were used to assess risk factors associated with CTI.

RESULTS: 214 male and 20 female inmates agreed to participate. Overall CTI prevalence was 6.5% in men (95% CI 3.2; 9.9) and 10% (95%CI 0; 23.1) in women. None of the following possible risk factors analysed were significantly correlated to CTI: age, origin, education, religion, number of sexual partners, iv drug use, subjective health status and uro-genital symptoms.

CONCLUSION: CTI prevalence in the largest Swiss prison was two to six times higher than in the general population but similar to other European prison settings. This result should raise our awareness that this population is at particularly high risk for sexually transmitted infections and motivate a widespread surveillance of prison CT prevalence. We hesitate to consider systematic screening because evidence is still lacking in relation to the benefits of screening in males. Local cost effectiveness studies would highly contribute to a correct decision concerning implementation of screening.

References

  1. Paget WJ, Zbinden R, Ritzler E, Zwahlen M, Lengeler C, Sturchler D, et al. National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland. Sex Transm Dis. 2002;29:715–20.
  2. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;147:128–34.
  3. LaMontagne DS, Fine DN, Marrazzo JM. Chlamydia trachomatis infection in asymptomatic men. Am J Prev Med. 2003;24:36–42.
  4. Cecil JA, Howell MR, Tawes JJ, Gaydos JC, McKee KT, Jr., Quinn TC, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis. 2001;184:1216–9.
  5. LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect. 2004;80:335–41.
  6. http://www.bag.admin.ch/k_m_meldesystem/00733/00804/index.html?lang=fr.
  7. Abraham S, Toutous-Trellu L, Pechere M, Hugonnet S, Liassine N, Yerly S, et al. Increased incidence of sexually transmitted infections in Geneva, Switzerland. Dermatology. 2006;212:41–6.
  8. Baud D, Jaton K, Bertelli C, Kulling JP, Greub G. Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men. BMC Infect Dis. 2008;8:45.
  9. Mertz KJ, Schwebke JR, Gaydos CA, Beidinger HA, Tulloch SD, Levine WC. Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates. Sex Transm Dis. 2002;29:271–6.
  10. Pack RP, Diclemente RJ, Hook EW, 3rd, Oh MK. High prevalence of asymptomatic STDs in incarcerated minority male youth: a case for screening. Sex Transm Dis. 2000;27:175–7.
  11. Barry PM, Kent CK, Scott KC, Snell A, Goldenson J, Klausner JD. Optimising sexually transmitted infection screening in correctional facilities: San Francisco, 2003–2005. Sex Transm Infect. 2007;83:416–8.
  12. Cook RL, St George K, Lassak M, Tran N, Anhalt JP, Rinaldo CR. Screening for Chlamydia trachomatis infection in college women with a polymerase chain reaction assay. Clin Infect Dis. 1999;28:1002–7.
  13. Gaydos CA, Howell MR, Pare B, Clark KL, Ellis DA, Hendrix RM, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med. 1998;339:739–44.
  14. Phillips RS, Hanff PA, Holmes MD, Wertheimer A, Aronson MD. Chlamydia trachomatis cervical infection in women seeking routine gynaecologic care: criteria for selective testing. Am J Med.1989;86:515–20.
  15. Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. 2007;147:89–96.
  16. Adams OP, Carter AO, Prussia P, McIntyre G, Branch SL. Risk behaviour, healthcare access and prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoeae in a population-based sample of adults in Barbados. Sex Transm Infect. 2008;84:192–4.
  17. Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public health. 2006;120:33–41.
  18. Khan MR, Wohl DA, Weir SS, Adimora AA, Moseley C, Norcott K, et al. Incarceration and risky sexual partnerships in a southern US city. J Urban Health. 2008;85:100–13.
  19. Pimenta J, Catchpole M, Gray M, Hopwood J, Randall S. Evidence based health policy report. Screening for genital chlamydial infection. BMJ. 2000;321:629–31.
  20. Workowski KA, Berman SM. Sexually Transmitted Diseases Treatment Guidelines. [Web page] 2006 [cited; Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5511a1.htm?s_cid=rr5511a1_x
  21. Barry PM, Kent CK, Scott KC, Goldenson J, Klausner JD. Is jail screening associated with a decrease in Chlamydia positivity among females seeking health services at community clinics?-San Francisco, 1997–2004. Sex Transm Dis. 2009;36:S22–8.
  22. Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al. Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France. Eur J Clin Microbiol Infect Dis. 2009;28:409–13.
  23. Kahn RH, Mosure DJ, Blank S, Kent CK, Chow JM, Boudov MR, et al. Chlamydia trachomatis and Neisseria gonorrhoeae prevalence and coinfection in adolescents entering selected US juvenile detention centers, 1997–2002. Sex Transm Dis. 2005;32:255–9.
  24. Trick WE, Kee R, Murphy-Swallow D, Mansour M, Mennella C, Raba JM. Detection of chlamydial and gonococcal urethral infection during jail intake: development of a screening algorithm. Sex Transm Dis. 2006;33:599–603.
  25. Bernstein KT, Chow JM, Ruiz J, Schachter J, Horowitz E, Bunnell R, et al. Chlamydia trachomatis and Neisseria gonorrhoeae infections among men and women entering California prisons. Am J Public Health. 2006;96:1862–6.
  26. Menon-Johansson AS, Winston A, Matthews G, Portsmouth S, Daniels D. The first point prevalence study of genital Chlamydia trachomatis infection in young male inmates in the UK. Int J STD AIDS. 2005;16:799–801.
  27. Sherrard J, Boss I, Law L. Experience of setting up a genitourinary medicine in-reach clinic in a male prison. Int J STD AIDS. 2007;18:228–30.
  28. Gabriel G, Burns T, Scott-Ram R, Adlington R, Bansi L. Prevalence of Chlamydia trachomatis and associated risk factors in women inmates admitted to a youth offenders institute in the UK. Int J STD AIDS. 2008;19:26–9.
  29. Skjeldestad FE, Marsico MA, Sings HL, Nordbo SA, Storvold G. Incidence and risk factors for genital Chlamydia trachomatis infection: a 4-year prospective cohort study. Sex Transm Dis. 2009;36:273–9.
  30. Bebear C, de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect. 2009;15:4–10.
  31. Latino MA, Caneparo A, Rosso C, De Maria D, De Intinis G, Intorcia P, et al. Prevalence and risk factors for Chlamydia trachomatis infection in young women in north-west of Italy. Minerva ginecologica. 2008;60:29–37.
  32. Buffardi AL, Thomas KK, Holmes KK, Manhart LE. Moving upstream: ecosocial and psychosocial correlates of sexually transmitted infections among young adults in the United States. Am J Public Health. 2008;98:1128–36.
  33. Stein CR, Kaufman JS, Ford CA, Leone PA, Feldblum PJ, Miller WC. Screening young adults for prevalent chlamydial infection in community settings. Ann Epidemiol. 2008;18:560–71.
  34. Kahn RH, Moseley KE, Thilges JN, Johnson G, Farley TA. Community-based screening and treatment for STDs: results from a mobile clinic initiative. Sex Transm Dis. 2003;30:654–8.
  35. Département Justice. Champ Dollon. Geneva: Champ Dollon; Rapport annuel 2008.
  36. Gift TL, Lincoln T, Tuthill R, Whelan M, Briggs LP, Conklin T, et al. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis. 2006;33:S103–10.
  37. Kraut-Becher JR, Gift TL, Haddix AC, Irwin KL, Greifinger RB. Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails. J Urban Health. 2004;81:453–71.